Predictors of Pain Relief in Chronic Pancreatitis Undergoing ESWL
Unknown statusNCT04490083
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Extra corporeal shock wave therapy (ESWL) is recommended for pain management in patients with stone formation in pancreatic duct. ESWL can cause complete stone fragmentation and removal in 70% patients, associated with 85 to 90% pain relief. Investigators aim to study, predictors pain relief in patients who undergo ESWL, to find out which patients will improve and which patients won't improve in terms of pain.
Study details
- Official title
- Predictors of Pain Relief and Stone Fragmentation in Patients Undergoing Extra Corporeal Shock Wave Lithotripsy for Chronic Pancreatitis
- Conditions
- Interventions
- Procedure: Extra corporeal shock wave lithotripsy
- Sponsor
- Asian Institute of Gastroenterology, India
- Start date
- 2020-07-01
- Primary completion
- 2020-12-31
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- India
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Chronic pancreatitis patients undergoing ESWL Exclusion Criteria: * Patients with multiple pancreatic duct stones * Patients with multiple pancreatic duct strictures * Pancreatic head mass * Patients with ascites * Pregnancy * Patients not giving consent for participation * Pseudocyst
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04490083